very +ve result with obvious impacts of the WH products on the total BP revenue and potential for Nextstellis growth $14.01 m huge upside from FY22 , if the same growth rate next year $50m could be made in revenue from Nextstellis alone and $100m the year after , with the marketing cost distributed amongst all 6 products , there is a big reduction on Nexstellis OPEX from last year and massive improvement in dermatology . Less waste after selling generics business and less amortization
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.25 |
Change
-0.150(2.78%) |
Mkt cap ! $426.5M | |||
| Open | High | Low | Value | Volume |
| $5.35 | $5.41 | $5.19 | $1.239M | 231.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $5.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.36 | 1000 | 1 |
View Market Depth
| Last trade - 16.11pm 25/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |